Atossa Genetics (ATOS) Has 'Informative' Pre-510(k) Meeing w/ FDA for ForeCYTE
Tweet Send to a Friend
Atossa Genetics, Inc. (Nasdaq: ATOS) announced that on November 14, 2013, Atossa attended a pre-510(k) submission meeting with the Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
